FULGENT GENETICS, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
FULGENT GENETICS, INC. (FLGT) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $334.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Equity
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $334.00K, a 3.19% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $4.20M, a 122.58% increase year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $357.00K, a 17.17% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-06-30 was $345.00K, a 36.58% decline year-over-year.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $3.04M, a 4.73% increase from fiscal 2024.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $2.90M, a 6.11% increase from fiscal 2023.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $2.73M, a 54.52% increase from fiscal 2022.
- FULGENT GENETICS, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2022 was $1.77M, a 57.45% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.00K 10-Q · filed 2026-07-30 | $4.53M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2026-03-31 | $4.20M 10-Q · filed 2026-07-30 | |||
| 2025-12-31 | $3.04M 10-K · filed 2026-02-27 | |||
| 2025-09-30 | $357.00K 10-Q · filed 2025-11-07 | $702.00K derived: sum of 2 quarters · filed 2026-07-30 | $2.59M derived: sum of 3 quarters · filed 2026-07-30 | |
| 2025-06-30 | $345.00K 10-Q · filed 2026-07-30 | $2.23M derived: sum of 2 quarters · filed 2026-07-30 | ||
| 2025-03-31 | $1.89M 10-Q · filed 2026-07-30 | |||
| 2024-12-31 | $2.90M 10-K · filed 2026-02-27 | |||
| 2024-09-30 | $431.00K 10-Q · filed 2025-11-07 | $975.00K derived: sum of 2 quarters · filed 2025-11-07 | $2.66M derived: sum of 3 quarters · filed 2025-11-07 | |
| 2024-06-30 | $544.00K 10-Q · filed 2025-11-07 | $2.23M derived: sum of 2 quarters · filed 2025-11-07 | ||
| 2024-03-31 | $1.68M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $2.73M 10-K · filed 2026-02-27 | |||
| 2023-09-30 | $517.00K 10-Q · filed 2024-11-08 | $749.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.62M derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $232.00K 10-Q · filed 2024-11-08 | $1.10M derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-03-31 | $869.00K 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $1.77M 10-K · filed 2025-02-28 | |||
| 2022-09-30 | $522.00K 10-Q · filed 2023-11-03 | $958.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.45M derived: sum of 3 quarters · filed 2023-11-03 | |
| 2022-06-30 | $436.00K 10-Q · filed 2023-11-03 | $930.00K derived: sum of 2 quarters · filed 2023-11-03 | ||
| 2022-03-31 | $494.00K 10-Q · filed 2023-11-03 | |||
| 2021-12-31 | $4.16M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $2.92M 10-Q · filed 2022-11-07 | $2.95M derived: sum of 2 quarters · filed 2022-11-07 | $3.47M derived: sum of 3 quarters · filed 2022-11-07 | |
| 2021-06-30 | $39.00K 10-Q · filed 2022-11-07 | $552.00K derived: sum of 2 quarters · filed 2022-11-07 | ||
| 2021-03-31 | $513.00K 10-Q · filed 2022-11-07 | |||
| 2020-12-31 | $62.00K 10-K · filed 2023-02-28 | |||
| 2020-03-31 | $46.00K 10-Q · filed 2021-11-09 | |||
| 2019-12-31 | $21.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |